Piero Pollesello

R&d
Espoo, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC.

How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC.

Journal: European journal of heart failure

Published: February 07, 2025

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.

Journal: European journal of heart failure

Published: October 29, 2024

Chronotropic Effects of Milrinone in a Guinea Pig Ex Vivo Model: A Pilot Study to Screen for New Mechanisms of Action.

Chronotropic Effects of Milrinone in a Guinea Pig Ex Vivo Model: A Pilot Study to Screen for New Mechanisms of Action.

Journal: Journal of cardiovascular pharmacology

Published: September 23, 2024

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases.

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases.

Journal: European journal of heart failure

Published: May 26, 2024

Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.

Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.

Journal: Journal of cardiovascular pharmacology

Published: May 08, 2024

Repetitive Treatments With Inotropes in Advanced Heart Failure.

Repetitive Treatments With Inotropes in Advanced Heart Failure.

Journal: Journal of cardiovascular pharmacology

Published: April 04, 2024

The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson's Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On.

The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson's Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On.

Journal: Neurology and therapy

Published: April 04, 2024

Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.

Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.

Journal: Journal of cardiovascular pharmacology

Published: August 25, 2023

A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.

A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.

Journal: European journal of heart failure

Published: July 26, 2023

Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine.

Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine.

Journal: ESC heart failure

Published: March 30, 2023

Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?

Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?

Journal: Drugs

Published: December 20, 2022

The Future for Inotropes in Heart Failure. Do Not Throw the Baby Out With the Bathwater!

The Future for Inotropes in Heart Failure. Do Not Throw the Baby Out With the Bathwater!

Journal: Journal of cardiovascular pharmacology

Published: November 16, 2022

Showing 1-12 of 82

Last Updated: 09/26/2026